Free Trial
LON:OCTP

Oxford Cannabinoid Technologies (OCTP) Share Price, News & Analysis

Oxford Cannabinoid Technologies logo

About Oxford Cannabinoid Technologies Stock (LON:OCTP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
0.12
0.12
52-Week Range
N/A
Volume
11.40 million shs
Average Volume
9.33 million shs
Market Capitalization
£1.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Receive OCTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter.

OCTP Stock News Headlines

Man who predicted $100K Bitcoin sees a huge run coming for another coin …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
Oxford Cann Share Chat
See More Headlines

OCTP Stock Analysis - Frequently Asked Questions

Shares of OCTP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Cannabinoid Technologies investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Brookfield Business Partners (BBU.UN), Bearing Lithium (BRZ), (BSFT) (BSFT), BTCS (BTCS) and BTC Digital (BTCTW).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OCTP
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-4,240,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,090,000,000
Free Float
N/A
Market Cap
£1.25 million
Optionable
Not Optionable
Beta
0.82
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:OCTP) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners